Internal Medicine, Medical Oncology · Charlotte, NC
NPI
1518965607
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1021 Morehead Medical Dr, Ste A
Charlotte, NC, 28204
Phone (980) 442-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
697 services
Medicare patients, 2024
194
Average age 74
Drug cost, 2024
$3.9M
693 prescriptions
Company payments, 2025
$4,373
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asim Amin was code 99215 (office e&m - established), 460 times for 156 patients. In total Asim Amin billed 697 services in 8 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 460 | 156 | $99.12 | $46K |
| 99214 Office E&M - Established | Facility | 180 | 76 | $66.31 | $12K |
| 99205 Office E&M - New | Facility | 37 | 37 | $130.96 | $4,846 |
By year: 2022 $77K for 797 services; 2023 $75K for 778 services; 2024 $64K for 697 services.
Medicare prescription drug claims, 2024
In 2024, the drug Asim Amin prescribed most often to Medicare patients was Levothyroxine Sodium, with 104 prescriptions and refills. In total Asim Amin wrote 693 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 104 | 224 | 31 | $938 |
| Prednisone Generic | 80 | 87 | 33 | $274 |
| Lenvima Lenvatinib Mesylate | 79 | 79 | 12 | $1.9M |
| Mektovi Binimetinib | 43 | 43 | Under 11 | $511K |
| Braftovi Encorafenib | 43 | 43 | Under 11 | $667K |
| Pantoprazole Sodium Generic | 30 | 54 | Under 11 | $321 |
| Everolimus Generic | 29 | 29 | Under 11 | $104K |
| Eliquis Apixaban | 24 | 34 | Under 11 | $11K |
| Dexamethasone Generic | 23 | 23 | 11 | $371 |
| Famotidine Generic | 22 | 32 | Under 11 | $134 |
| Triamcinolone Acetonide Generic | 21 | 39 | 15 | $337 |
| Budesonide Dr Budesonide | 20 | 24 | Under 11 | $1,676 |
| Welireg Belzutifan | 17 | 17 | Under 11 | $459K |
| Gabapentin Generic | 16 | 24 | Under 11 | $127 |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $59.37 |
Brand drugs: 271 claims; generic drugs: 422 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asim Amin $4,373 ($3,166 in general payments such as food, travel and fees and $1,207 for research) from 6 companies. The largest payer was Eisai Inc. with $3,024.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.